<h1 id="adenosine-6-12-12-adenosine-approach">Adenosine: 6-12-12 adenosine approach</h1>
<p>The ACLS-recommended dosing strategy of 6 mg, 12 mg, and 12 mg for <span class="drug">adenosine</span> may not be appropriate in every situation. There are a few instances when lower or higher dosing should be considered.</p>
<p><em>Caveat: </em>All recommendations are data-based, but many factors affect successful conversion of paroxysmal supraventricular tachycardia (PSVT) including proper line placement and administration technique.</p>
<p><strong>Option 1: Starting at higher dose</strong></p>
<p>Caffeine is an <span class="drug">adenosine</span>blocker and can interfere with the successful reversion of PSVT. In fact, ingestion of caffeine less than 4 hours before a 6-mg <span class="drug">adenosine</span> bolus significantly reduced its effectiveness in the treatment of PSVT. An increased initial <span class="drug">adenosine</span>dose may be indicated for these patients.</p>
<p>Remember that theophylline may require higher dosing as well, because it is similar to caffeine (another methylxanthine), but is not prescribed much in the U.S. anymore.</p>
<p><strong><em>Recommended dosing strategy</em></strong> [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20003123">Cabalag, 2009</a>]:</p>
<ul>
<li>1st dose: 12 mg (instead of 6)</li>
<li>2nd/3rd doses: 18 mg (instead of 12)</li>
</ul>
<p><strong>Option 2: Starting at lower dose</strong></p>
<p>Every so often a patient arrives in PSVT with their only IV access being through a hemodialysis port. The initial <span class="drug">adenosine</span>dose should be reduced if administered through a central line. Remember a central line delivers the <span class="drug">adenosine</span>right where you need it. This recommendation is supported by the 2010 ACLS guidelines. Cases of prolonged bradycardia and severe side effects have been reported after full-dose <span class="drug">adenosine</span>through a central line.
Also consider lower doses in patients concomitantly taking carbamazepine or dipyridamole or in those with a transplanted heart.</p>
<p><strong><em>Recommended dosing strategy</em> </strong>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11858927">Chang, 2002</a>; <a href="http://www.ncbi.nlm.nih.gov/pubmed/20956256">Neumar, 2010</a>; <a href="http://www.ncbi.nlm.nih.gov/pubmed/8354807">Mc-Intosh-Yellin, 1993</a>]:</p>
<ul>
<li>1st dose: 3 mg (instead of 6)</li>
<li>2nd/3rd doses: 6 mg (instead of 12)</li>
</ul>
<p><strong> <a href="http://academiclifeinem.com/heart-score-new-ed-chest-pain-risk-stratification-score/">ALiEM Blog Post</a> </strong></p>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/8354807">McIntosh-Yellin NL, et al. Safety and efficacy of central intravenous bolus administration for termination of supraventricular tachycardia. J Am Coll Cardiol 1993;22:741-5.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20003123">Cabalag MS, et al. Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med 2009;17(1):44-9.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/11858927">Chang M, et al. Adenosine dose should be less when administered through a central line. J Emerg Med 2002;22(2):195-8</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20956256">Neumar RW, et al. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S729-S767.</a></li>
</ul>
